Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.

ABSTRACT: BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022.METHODS: Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis.RESULTS: A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and

SUBMITTER: Stolbrink M 

PROVIDER: S-EPMC9621306 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature